mianserin and mdl 100907

mianserin has been researched along with mdl 100907 in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (15.79)18.2507
2000's7 (36.84)29.6817
2010's8 (42.11)24.3611
2020's1 (5.26)2.80

Authors

AuthorsStudies
Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D1
Griebel, G; Perrault, G; Sanger, DJ1
Dekeyne, A; Girardon, S; Millan, MJ1
Alsayegh, L; Backstrom, JR; Berry, SA; Friedman, L; Roth, BL; Sanders-Bush, E; Willins, DL1
Matsumoto, K; Morishige, R; Murakami, Y; Sakakibara, I; Takayama, H; Tohda, M; Watanabe, H1
Abreu, GR; Bissoli, NS; Cabral, AM; Pires, JG; Ramage, AG; Silva, AL1
Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R1
Alfinito, PD; Cosmi, S; Deecher, DC; Maswood, N; Pawlyk, AC1
Carley, DW; Olopade, C; Radulovacki, M; Ruigt, GS1
Ceccherini-Nelli, L; Focosi, D; Kast, RE; Lauria, G; Maggi, F; Petrini, M1
Chesselet, MF; De Deurwaerdère, P; Le Moine, C1
Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R; Meyer, PT1
Poyurovsky, M1
Foley, JJ; Walker, EA1
Farrell, M; Rosenzweig-Lipson, S; Walker, E1
Iwamura, T; Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T1
Atzori, C; Bonora, S; Busolli, P; Calcagno, A; Ghisetti, V; Imperiale, D; Trentalange, A1
El-Tanbouly, DM; Sayed, RH; Wadie, W1
Bucki, A; Czopek, A; Filipek, B; Kołaczkowski, M; Kubacka, M; Pawłowski, M; Siwek, A1

Trials

1 trial(s) available for mianserin and mdl 100907

ArticleYear
Efficacy of mirtazapine in obstructive sleep apnea syndrome.
    Sleep, 2007, Volume: 30, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polysomnography; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Sleep Apnea, Obstructive

2007

Other Studies

18 other study(ies) available for mianserin and mdl 100907

ArticleYear
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:2

    Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists

2004
A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
    Neuropharmacology, 1997, Volume: 36, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Drinking; Fluorobenzenes; Indoles; Male; Maze Learning; Mianserin; Mice; Mice, Inbred BALB C; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists

1997
Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
    Neuropharmacology, 1999, Volume: 38, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminopyridines; Animals; Conditioning, Operant; Ethylamines; Fluorobenzenes; Indoles; Male; Mianserin; Piperazines; Piperidines; Pyrazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Reinforcement, Psychology; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes

1999
Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
    Neuroscience, 1999, Volume: 91, Issue:2

    Topics: 3T3 Cells; Animals; Antipsychotic Agents; Benzodiazepines; Cell Line; Clozapine; Dendrites; Fluorobenzenes; Haloperidol; Mianserin; Mice; Olanzapine; Piperidines; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Risperidone; Ritanserin; Serotonin Antagonists; Transfection

1999
Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: behavioural and electrophysiological studies.
    European journal of pharmacology, 2005, Jul-11, Volume: 517, Issue:3

    Topics: Alkaloids; Aminopyridines; Animals; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Female; Indole Alkaloids; Ketanserin; Male; Membrane Potentials; Methoxydimethyltryptamines; Mianserin; Mice; Mice, Inbred ICR; Motor Activity; Oocytes; Oxindoles; Patch-Clamp Techniques; Piperazines; Rats; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Xenopus

2005
Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
    European journal of pharmacology, 2005, Aug-22, Volume: 518, Issue:2-3

    Topics: Animals; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Drinking; Heart Rate; Hypertension; Injections, Intraventricular; Male; Mianserin; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sodium; Time Factors; Urodynamics; Weight Gain

2005
Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2007, Volume: 27, Issue:1

    Topics: Adult; Antidepressive Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Female; Fluorobenzenes; Humans; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Models, Statistical; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Reproducibility of Results; Serotonin Antagonists; Spectrophotometry, Ultraviolet

2007
Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation.
    Brain research, 2006, Dec-06, Volume: 1123, Issue:1

    Topics: Animals; Body Temperature Regulation; Dose-Response Relationship, Drug; Female; Hot Flashes; Mianserin; Mirtazapine; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists

2006
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.
    The Journal of infectious diseases, 2008, Jan-15, Volume: 197, Issue:2

    Topics: Adult; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middle Aged; Mirtazapine; Polycythemia Vera; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists

2008
Selective blockade of serotonin 2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia.
    Neuroscience letters, 2010, Jan-22, Volume: 469, Issue:2

    Topics: Animals; Corpus Striatum; Globus Pallidus; Indoles; Male; Mianserin; Photomicrography; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Substantia Nigra; Subthalamic Nucleus

2010
Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
    NeuroImage, 2010, Apr-15, Volume: 50, Issue:3

    Topics: Adult; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Kinetics; Linear Models; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Piperidines; Positron-Emission Tomography; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Signal Processing, Computer-Assisted

2010
Acute antipsychotic-induced akathisia revisited.
    The British journal of psychiatry : the journal of mental science, 2010, Volume: 196, Issue:2

    Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Humans; Mianserin; Mirtazapine; Practice Guidelines as Topic; Serotonin 5-HT2 Receptor Antagonists

2010
Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure.
    Behavioural pharmacology, 2010, Volume: 21, Issue:2

    Topics: Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Inverse Agonism; Drug Partial Agonism; Indoles; Ligands; Lysergic Acid Diethylamide; Male; Memory; Methysergide; Mianserin; Mice; Piperazines; Pyrazines; Pyridines; Reinforcement Schedule; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors

2010
Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.
    Psychopharmacology, 2010, Volume: 211, Issue:2

    Topics: Animals; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Drug Inverse Agonism; Male; Methysergide; Mianserin; Pyrazines; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists

2010
The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Neuroscience letters, 2011, Jul-15, Volume: 499, Issue:1

    Topics: Animals; Antidepressive Agents, Tricyclic; Disease Models, Animal; Fever; Fluoxetine; Male; Mianserin; Mirtazapine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents

2011
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
    Antiviral therapy, 2016, Volume: 21, Issue:7

    Topics: Aged; DNA, Viral; Female; Humans; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mianserin; Mirtazapine; Sarcoidosis; Serotonin 5-HT2 Receptor Antagonists

2016
Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice.
    Toxicology and applied pharmacology, 2017, 08-15, Volume: 329

    Topics: Animals; Antioxidants; Collagen; Glutathione; Hepatic Stellate Cells; Hypertension, Portal; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; Mianserin; Mice; Mirtazapine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Oxidative Stress; Phosphorylation; Protein Kinase C; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Smad3 Protein; Thioacetamide; Transforming Growth Factor beta1

2017
Novel serotonin 5-HT
    Pharmacological reports : PR, 2021, Volume: 73, Issue:5

    Topics: Animals; Aorta; CHO Cells; Cricetinae; Cricetulus; Humans; Hydantoins; Mianserin; Models, Molecular; Molecular Structure; Platelet Aggregation Inhibitors; Protein Conformation; Rats; Serotonin 5-HT2 Receptor Antagonists

2021